Agios Pharma (AGIO)
NASDAQ:AGIO
Holding AGIO?
Track your performance easily

Agios Pharma (AGIO) Technical Analysis

570 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Agios Pharma’s (AGIO) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting Agios Pharma is a Sell.
Agios Pharma’s (AGIO) 20-Day exponential moving average is 45.20, while Agios Pharma’s (AGIO) share price is $47.63, making it a Buy.
Agios Pharma’s (AGIO) 50-Day exponential moving average is 44.59, while Agios Pharma’s (AGIO) share price is $47.63, making it a Buy.

Agios Pharma (AGIO) Pivot Points

Sep 19, 2024, 09:11 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
43.34
44.33
45.01
46.00
46.68
47.67
48.35
Fibonacci
44.33
44.97
45.36
46.00
46.64
47.03
47.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Agios Pharma (AGIO) Moving Averages

Sep 19, 2024, 09:11 PM
Period
Simple
Exponential
MA5
45.65Sell
45.46Buy
MA10
44.83Buy
45.27Buy
MA20
45.38Buy
45.20Buy
MA50
45.58Sell
44.59Buy
MA100
42.47Buy
41.85Buy
MA200
34.49Buy
35.33Buy
Agios Pharma’s (AGIO) 10-Day exponential moving average is 45.27, while Agios Pharma’s (AGIO) share price is $47.63, making it a Buy.
Agios Pharma’s (AGIO) 100-Day exponential moving average is 41.85, while Agios Pharma’s (AGIO) share price is $47.63, making it a Buy.
Agios Pharma’s (AGIO) stock price is $47.63 and Agios Pharma’s (AGIO) 50-day simple moving average is 45.58, creating a Sell signal.
Agios Pharma’s (AGIO) stock price is $47.63 and Agios Pharma’s (AGIO) 100-day simple moving average is 42.47, creating a Buy signal.
Agios Pharma’s (AGIO) stock price is $47.63 and Agios Pharma’s (AGIO) 200-day simple moving average is 34.49, creating a Buy signal.

Agios Pharma (AGIO) Technical Indicators

Sep 19, 2024, 09:11 PM
Name
Value
Implied Action
RSI (14)
52.04
Neutral
STOCH (9,6)
61.72
Neutral
STOCHRSI (14)
46.89
Neutral
MACD (12,26)
0.06
Sell
ADX (14)
15.11
Buy
Williams %R
-40.09
Buy
CCI (14)
42.40
Neutral
ATR (14)
1.79
-
Ultimate Oscillator
49.15
Neutral
ROC
0.40
Buy
Agios Pharma’s (AGIO) Relative Strength Index (RSI) is 52.04, creating a Neutral signal.
Agios Pharma’s (AGIO) Trend Strength Indicator (ADX) is 15.11, creating a Buy signal.
Agios Pharma’s (AGIO) Commodity Channel Index (CCI) is 42.40, creating a Neutral signal.
Agios Pharma’s (AGIO) Price Rate of Change (ROC) is 0.40, creating a Buy signal.

FAQ

Is AGIO a Buy, Hold, or Sell?
Based on AGIO’s technical indicators, AGIO is a Buy.
    What is AGIO’s RSI (14)?
    AGIO’s RSI (14) is 52.04, which suggests AGIO is a Neutral.
      What is AGIO’s MACD?
      AGIO’s MACD is 0.06, which suggests AGIO is a Sell.
        What is AGIO’s 5-day moving average?
        AGIO’s 5-day moving average is 45.65, which suggests AGIO is a Sell.
          What is AGIO’s 20-day moving average?
          AGIO 20-day moving average is 45.38, which suggests AGIO is a Buy.
            What is AGIO’s 50-day moving average?
            AGIO’s 50-day moving average is 45.58, which suggests AGIO is a Sell.
              What is AGIO’s 200-day moving average?
              AGIO’s 200-day moving average is 34.49, which suggests AGIO is a Buy.
                What is AGIO’s Williams % R (14)?
                AGIO’s Williams % R (14) is -40.09, which suggests AGIO is a Buy.
                  What is AGIO’s CCI (14)?
                  AGIO’s CCI (14) is 42.40, which suggests AGIO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis